IGTP presents its 2023 Annual Report
The report compiles the institution's key numbers and objectives, as well as its research activities. For the first time, the report also includes a web version that summarises the most relevant aspects.
At the IGTP TODAY
News
New study finds a promising combined therapy for multiple sclerosis
Researchers from Barcelona's Germans Trias i Pujol Institute and Josep Carreras Leukaemia Research Institute have found a potential new way to improve the treatment of multiple sclerosis (MS) using a novel combined therapy. The results, published in the Journal of Clinical Investigation, builds on two harmonized Phase I clinical trials funded by the European Union, focusing on the use of Vitamin D3 tolerogenic dendritic cells (VitD3-tolDCs) to regulate the immune response in MS patients. The team is now preparing to move into Phase II trials to further explore these findings.
Notable presence of IGTP researchers at European Researchers' Night
Several researchers from IGTP took part in this year's European Researchers' Night in Barcelona. They shared their passion for science through talks and led participants of a workshop via a board game into the midst of a tuberculosis epidemic.
A new episode of the podcast 'Un bri de ciència' focuses on respiratory diseases
Researcher Raquel Guillamat Prats discusses her research on respiratory diseases such as pulmonary fibrosis, respiratory infections, and lung cancer. She also shares her experience of establishing a research group from scratch at IGTP.
Mitral valve repair via catheter offers better outcomes than pharmacological treatment in patients with heart failure
A new study, published in New England Journal of Medicine, has demonstrated the benefits of placing a clip on the valve instead of the usual medical treatment. The study includes the participation of Professor Antoni Bayés-Genís, principal investigator of the ICREC group and Director of the Heart Institute at Germans Trias Hospital.
_1725960548.jpg)
The Research Institute of the Germans Trias i Pujol Hospital demonstrates how personalised medicine helps to control the effects of acromegaly earlier
IGTP leading the first study in the world to prove that personalised therapies are more effective than classic drugs indicated for the treatment of this rare hormonal disease. It is based on response biomarkers that, depending on what they indicate, allow the best possible treatment to be assigned earlier. In addition to very noticeable facial and skeletal deformities, acromegaly causes severe alterations in other parts of the body. Published in The Journal of Clinical Endocrinology & Metabolism.
_1723033241.jpg)
IGTP obtains reaccreditation as Instituto de Investigación Sanitaria by Instituto de Salud Carlos III
This recognition consolidates the position of the IIS-IGTP as a reference centre in the management of biomedical research at the national level and ensures its status as an IIS for the next five years.
The Comparative Medicine and Bioimage Centre of Catalonia celebrates its fifth anniversary
CMCiB celebrated its first five years of activity with a symposium dedicated to pioneering biomedical research at CosmoCaixa.
Innomed Awards drive biomedical innovation
The Innomed Awards, held at the Can Ruti Campus, celebrated significant advancements in biomedical innovation and reinforced the commitment to collaboration among the leading healthcare and research institutions of this health ecosystem and its surroundings.
IGTP closes another round of La Marató visits to its laboratories
Once again, the "Visita la recerca" program of Fundació La Marató de TV3 has successfully concluded at Germans Trias i Pujol Research Institute (IGTP), where a score of collaborators had the opportunity to discover firsthand the research projects supported through this charitable initiative.
_1717754567.png)